Revenue (Tables)

9 Months Ended

Jul. 31, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:

	Three Months Ended July 31,
	2020								2019
	Life Sciences and Applied Markets		Agilent CrossLab		Diagnostics and Genomics		Total		Life Sciences and Applied Markets		Agilent CrossLab		Diagnostics and Genomics		Total
	(in millions)
Revenue by Region
Americas	$	174	$	156	$	121	$	451	$	160	$	167	$	138	$	465
Europe	111		127		84		322		118		130		91		339
Asia Pacific	272		180		36		488		266		170		34		470
Total	$	557	$	463	$	241	$	1,261	$	544	$	467	$	263	$	1,274

	Nine Months Ended July 31,
	2020								2019
	Life Sciences and Applied Markets		Agilent CrossLab		Diagnostics and Genomics		Total		Life Sciences and Applied Markets		Agilent CrossLab		Diagnostics and Genomics		Total
	(in millions)
Revenue by Region
Americas	$	553	$	484	$	365	$	1,402	$	473	$	491	$	367	$	1,331
Europe	389		391		268		1,048		407		390		279		1,076
Asia Pacific	779		507		120		1,406		800		483		106		1,389
Total	$	1,721	$	1,382	$	753	$	3,856	$	1,680	$	1,364	$	752	$	3,796

The following table presents the company’s total revenue disaggregated by end markets and by revenue type:

	Three Months Ended				Nine Months Ended
	July 31,				July 31,
	2020		2019		2020		2019
	(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical	$	440	$	416	$	1,263	$	1,178
Chemical and Energy	260		291		839		899
Diagnostics and Clinical	178		198		572		578
Food	123		116		367		359
Academia and Government	119		103		375		333
Environmental and Forensics	141		150		440		449
Total	$	1,261	$	1,274	$	3,856	$	3,796
Revenue by Type
Instrumentation	$	526	$	505	$	1,610	$	1,563
Non-instrumentation and other	735		769		2,246		2,233
Total	$	1,261	$	1,274	$	3,856	$	3,796

Contract Liabilities and Changes in Balances

The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the nine months ended July 31, 2020:

	Contract Liabilities
	(in millions)
Ending balance as of October 31, 2019	$	386
Net revenue deferred in the period	331
Revenue recognized that was included in the contract liability balance at the beginning of the period	(273		)
Change in deferrals from customer cash advances, net of revenue recognized	3
Currency translation and other adjustments	4
Ending balance as of July 31, 2020	$	451